Lennart T H Jacobsson Selected Research

Lennart T H Jacobsson Research Topics

Disease

19	Rheumatoid Arthritis 01/2022 - 01/2005
9	Ankylosing Spondylitis 01/2022 - 02/2012
7	Necrosis 11/2021 - 05/2007
7	Psoriatic Arthritis 01/2021 - 10/2010
6	Gout 01/2022 - 01/2016
6	Pain (Aches) 01/2020 - 01/2002
6	Arthritis (Polyarthritis) 05/2015 - 06/2009
5	Fatigue 02/2016 - 01/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 07/2005
3	Atherosclerosis 01/2020 - 01/2008
2	Anterior Uveitis 11/2021 - 05/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
2	Dementia (Dementias) 01/2021 - 01/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 05/2015
2	Obesity 10/2020 - 01/2018
2	Hypertension (High Blood Pressure) 10/2020 - 01/2020
2	Dyslipidemias (Dyslipidemia) 10/2020 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2016
2	Axial Spondyloarthritis 10/2018 - 02/2016
2	Inflammation (Inflammations) 01/2018 - 11/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Myocardial Infarction 04/2021
1	Osteoporosis 01/2021
1	Diabetes Mellitus 10/2020
1	Gouty Arthritis 11/2019
1	Synovitis 10/2019
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019
1	Tuberculosis (Tuberculoses) 10/2018
1	Non-Radiographic Axial Spondyloarthritis 01/2017
1	Neoplasms (Cancer) 01/2017
1	Back Pain (Backache) 02/2016
1	Chronic Pain 11/2014
1	Spondylarthritis (Spinal Arthritis) 10/2010
1	Angina Pectoris 10/2009
1	Felty Syndrome (Syndrome, Felty's) 01/2005
1	Rheumatoid Vasculitis 01/2005
1	Xerostomia 01/2002

Drug/Important Bio-Agent (IBA)

12	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 07/2005
11	Uric Acid (Urate)IBA 01/2022 - 01/2016
7	Biological ProductsIBA 01/2022 - 06/2009
4	secukinumabIBA 01/2022 - 01/2021
4	Pharmaceutical PreparationsIBA 01/2020 - 06/2009
4	Adalimumab (Humira)FDA Link 01/2018 - 02/2012
3	AutoantibodiesIBA 01/2022 - 03/2011
3	ORALIT (ORS)IBA 01/2022 - 10/2009
3	Antirheumatic Agents (DMARD)IBA 10/2021 - 12/2016
3	ametantrone (HAQ)IBA 01/2020 - 09/2009
3	C-Reactive ProteinIBA 01/2020 - 12/2018
3	Infliximab (Remicade)FDA Link 01/2019 - 02/2012
3	Etanercept (Enbrel)FDA Link 01/2019 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2005
2	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 10/2019
2	DiureticsIBA 10/2020 - 01/2018
2	Rheumatoid FactorIBA 10/2019 - 01/2018
1	InterleukinsIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Amyloidogenic ProteinsIBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	acetyl 4-aminosalicylic acidIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	AntioxidantsIBA 01/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2018
1	HDL CholesterolIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	LipidsIBA 01/2018
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 02/2016
1	tocilizumab (atlizumab)FDA Link 07/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2014
1	Testosterone (Sustanon)FDA Link 03/2014
1	AntibodiesIBA 12/2013
1	VimentinIBA 12/2013
1	factor AIBA 10/2013
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2005
1	HLA-DRB1*04 antigenIBA 01/2005
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2005
1	HLA-DRB1*04:01 antigenIBA 01/2005
1	EpitopesIBA 01/2005
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2002
1	evening primrose oilIBA 01/2002
1	Lubricant Eye Drops (Artificial Tears)IBA 01/2002
1	AcidsIBA 01/2002
1	Analgesics (Analgesic Drugs)IBA 01/2002

Therapy/Procedure

10	Therapeutics 10/2018 - 01/2008
1	Biological Therapy 11/2021
1	Secondary Prevention 04/2021